Coal Mine Dust-induced Interstitial Lung Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-02-24
Clinical Trial Update: Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease [Phase 3]
Phase 3 trial of nintedanib for progressive fibrosing coal mine dust-induced interstitial lung disease has been withdrawn.